Clinical outcomes of pharmacological therapies for heart failure in Black vs. White populations: a meta-analysis of randomized controlled trials of heart failure treatment
ObjectiveTo evaluate the effect of different pharmacological therapies for heart failure (HF) between the Black vs. White population.MethodWe included randomized controlled trials (RCT) of HF pharmacological therapies with explicit strata of Black or White adults in the primary or secondary analysis...
Saved in:
| Main Authors: | Yujia Li, Huilin Tang, Wenxi Huang, Wei-Han Chen, Shao-Hsuan Chang, Jiang Bian, Mustafa M. Ahmed, Stephen E. Kimmel, Jingchuan Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1482311/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The most effective combination of pharmacological therapy for heart failure with reduced ejection fraction: a network meta-analysis of randomized controlled trials
by: Huilin Tang, et al.
Published: (2024-11-01) -
2024 update in heart failure
by: Alberto Beghini, et al.
Published: (2025-02-01) -
Timing and Adherence Matter for Sodium–Glucose Cotransporter‐2 Inhibitors in Heart Failure
by: Mehmet Birhan Yilmaz, et al.
Published: (2025-04-01) -
Impact of SGLT-2 Inhibitors on Biomarkers of Heart Failure
by: Dana Darwish, et al.
Published: (2025-06-01) -
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failure
by: Yuliya Lytvyn, et al.
Published: (2025-04-01)